# Excision BioTherapeutics Inc — Form D

Excision BioTherapeutics Inc of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-22. The offering totals $63.8M, of which $60.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-02-22
- Form: D
- Accession: 0001847173-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $63.8M
- Amount sold: $60.7M
- Remaining: $3.0M
- Minimum investment: $1
- Investors: 32
- Date of first sale: 2021-02-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-390027

## Issuer

- Name: Excision BioTherapeutics Inc
- CIK: 0001847173
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 988 MARKET STREET, SECOND FLOOR, SAN FRANCISCO, CA, 94102
- Phone: (404) 229-1162

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Ashok Krishnamurthi | Director | San Francisco, CA |
| Vasudev Bailey | Director | New Yoprk City, NY |
| William Carson | Director | Oakland, CA |
| Daniel Dornbusch | Director | San Francisco, CA |
| Daniel Dornbusch | Executive Officer | San Francisco, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-03-03](https://search.stillhousedata.com/formd/0001847173-21-000002) | D | $10.5M | $10.5M |

## More

- [CIK 1847173 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1847173&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001847173-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.